主页 > 医药生命 >

4月5日nature news和 business两篇和医药相关文章

Nature 446, 590-591 (5 April 2007) | doi:10.1038/446590a; Published online 4 April 2007

China plans to modernize traditional medicine

Jane Qiu, Beijing
Top of page
Abstract

Government initiative aims to meet scientific standards.

China has announced an ambitious attempt to bring the ancient practice of traditional Chinese medicine (TCM) into line with modern standards. The government says it will expand basic and clinical research, and improve the testing and developing of TCM remedies for export. But critics question whether the research will meet the scientific standards necessary for international recognition.

Although China has invested in TCM before, the 15-year plan involves a change of direction and will receive significantly more money. The project is backed by 16 Chinese ministries, spearheaded by the Ministry of Science and Technology (MOST), the Ministry of Health and the State Administration of Traditional Chinese Medicine (SATCM).

Zou Jian-qiang, director of MOST's health and biotechnology division, says the government has earmarked 1 billion yuan (US$130 million) for TCM research and development, with the total budget over the next five years increasing to at least 5–6 times as much as the previous total of 740 million yuan.
China plans to modernize traditional medicine

YANG LIU/CORBIS

Traditional Chinese medicine uses mixtures of plant extracts in a holistic approach to disease.

In a country where most of the population is not covered by the public healthcare system and cannot afford to go to hospital, there is also a tenfold increase in money for the TCM-related part of the public healthcare system to 8.5 billion yuan. "Chinese medicine, which has served the Chinese people since antiquity, still has an important role in today's healthcare, especially in areas where people do not have access to, or could not afford, treatments based on Western medicine," says Yu Wen-ming, deputy director of SATCM.

The initiative comes after heated discussions on TCM throughout China. Last year, Zhang Gong-yao, a scholar at the Central South University in Changsha, Hunan, sparked a national debate when he published an article titled "Farewell to Traditional Chinese Medicine" in the Chinese journal Medicine and Philosophy (27, 14–17; 2006). Zhang argued that TCM is a pseudoscience and should not be part of public healthcare and research.

All sides of the argument have been keenly awaiting the government's stance, and it has come down firmly in favour of promoting TCM as a science. China is desperate to earn regulatory approval for TCM remedies abroad, and hopes to globalize TCM by 2020. The world market for Chinese herbal medicine has doubled over the past decade, with Europe and the United States being the biggest importers. But the patchy safety record of TCM from China has led to a steady decline in its exports, and it has lost market share to neighbouring nations such as Japan and South Korea.

So China's plan specifies strategies to boost standards, including conducting clinical research on the safety and efficacy of TCM remedies, encouraging international collaboration, improving manufacturing techniques and bringing the drug regulatory system into line with international guidelines.

More controversial is the government's shift in approach. Previous attempts to develop scientifically tested drugs from TCM have focused on isolating active ingredients from the remedies and screening them one at a time. This has led to a handful of new treatments, such as artemisinin for treating malaria and the decongestant ephedrine, but there has been no goldrush of approved drugs. The new plan aims to develop methodologies to test TCM's more traditional features and principles. The practice takes a holistic approach to disease treatment, so rather than using one drug to treat a particular disease, complex combinations of plant extracts are used. Each mixture is personalized to the symptoms and characteristics of the patient.

TCM practitioners and researchers are still waiting to see whether the government will actually come up with the money, but they have generally welcomed the plan. "It's a significant step forward," says Liu Ping, vice-president of Shanghai University of Traditional Chinese Medicine. Some, however, are reluctant to jump on the bandwagon. A professor at the China Academy of Chinese Medical Sciences in Beijing, who asked not be named, reckons that after thousands of years of practice and development, TCM is already close to perfect and that modernization will simply distort its essence.

Shi-min Fang, a US-trained biochemist who now runs a website called 'New Threads' that fights pseudoscience and research misconduct in China, is also unimpressed by the plan, but for opposite reasons. He is in favour of scientific research into Chinese herbal remedies, but thinks the emphasis on testing the theories of TCM is misplaced. "The basic concepts of Chinese medicine, such as yin and yang, wu xing (the five elements) and the qi (meridian) theory, are inaccurate descriptions of the human body that verge on imaginative," he says. "The government has already spent a lot of money trying to prove their mechanistic basis, but this hasn't gone anywhere."

阅读本文的人还阅读:

【medical-news】记忆障碍主

【技术产业】科技部:将

医药技术市场渐入佳境

【社会人文】《时代》

收缩压增高与脑内出血病

作者:admin@医学,生命科学    2011-08-29 05:11
医学,生命科学网